Stocks · Health care · Pharmaceutical Preparations

BridgeBio Pharma, Inc.

BBIO Clue Score39
United States Fiscal year ends December CIK 0001743881 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jennifer E. Cook
9 Jul 2026
Director
Sold after exercise
112,422
$90.00
$10.12M
Jennifer E. Cook
9 Jul 2026
Director
Sold after exercise
36,167
$84.00
$3.04M
Andrea Ellis
9 Jul 2026
Director
Sold after exercise
17,167
$84.00
$1.44M
Jennifer E. Cook
24 Jun 2026
Director
Sold after exercise
37,167
$70.00
$2.60M
Hannah Valantine
22 Jun 2026
Director
Sold after exercise
2,808
$68.00
$190.94K
Jennifer E. Cook
15 Jun 2026
Director
Sold after exercise
1,503
$67.14
$100.92K
Jennifer E. Cook
15 Jun 2026
Director
Sold after exercise
88,737
$66.62
$5.91M
Randal W. Scott
15 May 2026
Director
Sold after exercise
200
$69.12
$13.82K
Randal W. Scott
15 May 2026
Director
Sold after exercise
1,512
$68.23
$103.16K
Randal W. Scott
15 May 2026
Director
Sold after exercise
2,088
$67.53
$141.00K
Randal W. Scott
15 May 2026
Director
Sold after exercise
6,200
$66.69
$413.46K
Hannah Valantine
10 Mar 2026
Director
Sold after exercise
8,671
$72.00
$624.31K
Andrea Ellis
4 Mar 2026
Director
Sold after exercise
64,921
$64.87
$4.21M
Hannah Valantine
27 Feb 2026
Director
Sold after exercise
10,900
$67.84
$739.50K
Hannah Valantine
27 Feb 2026
Director
Sold after exercise
14,584
$67.08
$978.28K
Randal W. Scott
17 Feb 2026
Director
Sold after exercise
3,307
$75.93
$251.09K
Randal W. Scott
17 Feb 2026
Director
Sold after exercise
4,793
$75.57
$362.22K
Randal W. Scott
17 Feb 2026
Director
Sold after exercise
1,900
$74.34
$141.25K
Randal W. Scott
17 Nov 2025
Director
Sold after exercise
6,199
$66.89
$414.66K
Randal W. Scott
17 Nov 2025
Director
Sold after exercise
3,801
$66.25
$251.81K
Hannah Valantine
12 Nov 2025
Director
Sold after exercise
25,484
$66.07
$1.68M
Ronald J Daniels
6 Nov 2025
Director
Sold after exercise
61,031
$63.72
$3.89M

What was left out

Form 4 filings counted 61
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 128
Sales straight out of an exercise 22
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 1,246,438
History held since 26 Jun 2018